FDA Inspection
Alembic Pharmaceuticals LimitedAlembic Pharmaceuticals Limited – FDA Inspection, Mar 20, 2018
Record Details
This FDA Inspection record concerns Alembic Pharmaceuticals Limited, with an inspection on March 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 4b3044f7-5634-4ca9-8f1d-9dd3f62ede6a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1048097
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Alembic Pharmaceuticals Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 26, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 13, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 26, 2018 | OAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| March 25, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 20, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Alembic Pharmaceuticals Limited
- FDA Inspection 1242965 - 2024-07-26
- FDA Inspection 1123365 - 2020-03-13
- FDA Inspection 1069852 - 2018-10-26
- FDA Inspection 967744 - 2016-03-25
- FDA Inspection 921484 - 2015-02-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.